BUFFERIN LOW DOSE BUFFERED ASPIRIN
-
aspirin tablet
Novartis Consumer Health, Inc.
Buffered aspirin equal to 81 mg aspirin (NSAID)*
(buffered with calcium carbonate, magnesium carbonate and magnesium oxide)
*nonsteroidal anti-inflammatory drug
Pain reliever
Reye’s syndrome: Children and teenagers who have or are recovering from chicken pox or flu-like symptoms should not use this product. When using this product, if changes in behavior with nausea and vomiting occur, consult a doctor because these symptoms could be an early sign of Reye’s syndrome, a rare but serious illness.
Aspirin may cause a severe allergic reaction which may include:
• hives • facial swelling • asthma (wheezing) • shock
Stomach bleeding warning: This product contains an NSAID, which may cause severe stomach bleeding. The chance is higher if you:
ask a health professional before use. It is especially important not to use aspirin during the last 3 months of pregnancy unless definitely directed to do so by a doctor because it may cause problems in the unborn child or complications during delivery.
In case of overdose, get medical help or contact a Poison Control Center right away.
ADDITIONAL INFORMATION LISTED ON OTHER PANELS
Product description -- Round, white film-coated tablets debossed with “ b “ on one side
TAMPER-EVIDENT BOTTLE
DO NOT USE IF INNER FOIL SEAL IMPRINTED WITH “SEALED for YOUR PROTECTION”
IS BROKEN OR MISSING
benzoic acid, carnauba wax, corn starch, FD&C blue #1, hypromellose, light mineral oil, magnesium stearate, microcrystalline cellulose, polysorbate 20, polysorbate 80, povidone, pregelatinized starch, propylene glycol, simethicone emulsion, sorbitan monolaurate, talc, titanium dioxide
1-800-468-7746
Dist. by: Novartis Consumer Health, Inc.
Parsippany, NJ 07054-0622 ©20##
BUFFERIN
LOW DOSE BUFFERED ASPIRIN aspirin tablet | ||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||
|
Marketing Information | |||
Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
OTC monograph final | part343 | 03/11/2022 |
Labeler - Novartis Consumer Health, Inc. (879821635) |
Establishment | |||
Name | Address | ID/FEI | Operations |
Novartis Consumer health | 129836151 | ANALYSIS, MANUFACTURE |